Erlotinib Completed Phase 1 Trials for Adenocarcinoma of the Stomach / Stage II Esophageal Cancer / Stage III Esophageal Cancer / Squamous Cell Carcinoma of the Esophagus / Stage III Gastric Cancer / Adenocarcinoma of the Esophagus / Adenocarcinomas of the Gastroesophageal Junction / Malignant Neoplasm of Stomach Stage II Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01561014Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction